Beta blockers in neuroleptic-induced akathisia.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D017109:Akathisia, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D011433:Propranolol